Prevalence of mutated TP53 on cDNA (but not on DNA template) in pleomorphic xanthoastrocytoma with positive TP53 immunohistochemistry

Cancer Genetics and Cytogenetics

Volumn 193, Issue 2, 2009, Pages 93-97

  Zakrzewska, Magdalena ^a   Szybka, Malgorzata ^a   Biernat, Wojciech ^a,b   Papierz, Tomasz ^a   Rieske, Piotr ^a   Liberski, Pawel P ^a   Zakrzewski, Krzysztof ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53; PROTEIN SMARCB1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ASTROCYTOMA; CASE REPORT; CHILD; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PLEOMORPHIC XANTHOASTROCYTOMA; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ASTROCYTOMA; DNA, COMPLEMENTARY; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; POLYMERASE CHAIN REACTION; TEMPLATES, GENETIC; XANTHOMATOSIS;

EID: 68049092153     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.04.023     Document Type: Article

References (17)

1. Kordek R., Biernat W., Sapieja W., Alwasiak J., and Liberski P.P. Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study. Acta Neuropathol 89 (1995) 194-197
2. Im S.H., Chung C.K., Kim S.K., Cho B.K., Kim M.K., and Chi J.G. Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes. J Neurooncol 66 (2004) 17-27
3. Giannini C., Paulus W., Louis D.N., and Liberski P.P. Pleomorphic xanthoastrocytoma. In: Louis D.N., Ohgaki H., Wiestler O.D., and Cavenee W.K. (Eds). WHO classification of tumours of the central nervous system. 4th ed. World Health Organization Classification of Tumours (2007), WHO Press, Geneva 22-24
4. Giannini C., Scheithauer B.W., Lopes M.B., Hirose T., Kros J.M., and VandenBerg S.R. Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 26 (2002) 479-485
5. Powell S.Z., Yachnis A.T., Rorke L.B., Rojiani A.M., and Eskin T.A. Divergent differentiation in pleomorphic xanthoastrocytoma: evidence for a neuronal element and possible relationship to ganglion cell tumors. Am J Surg Pathol 20 (1996) 80-85
6. Giannini C., Hebrink D., Scheithauer B.W., Dei Tos A.P., and James C.D. Analysis of TP53 mutation and expression in pleomorphic xanthoastrocytoma. Neurogenetics 3 (2001) 159-162
7. Kaulich K., Blaschke B., Nümann A., von Deimling A., Wiestler O.D., Weber R.G., and Reifenberger G. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas. J Neuropathol Exp Neurol 61 (2002) 1092-1099
8. Paulus W., Lisle D.K., Tonn J.C., Wolf H.K., Roggendorf W., Reeves S.A., and Louis D.N. Molecular genetic alterations in pleomorphic xanthoastrocytoma. Acta Neuropathol 91 (1996) 293-297
9. Marton E., Feletti A., Orvieto E., and Longatti P. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature. J Neurol Sci 252 (2007) 144-153
10. Nasuha N.A., Daud A.H., Ghazali M.M., Yusoff A.A., Zainuddin N., Abdullah J.M., Mutum S.S., Biswal B.M., Ariff A.R., Sulong S., and Isa M.N. Molecular genetic analysis of anaplastic pleomorphic xanthoastrocytoma. Asian J Surg 26 (2003) 120-125
11. ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene 26 (2007) 1088-1097
12. Chacko G., Chacko A.G., Dunham C.P., Judkins A.R., Biegel J.A., and Perry A. Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma. J Neurooncol 84 (2007) 217-222
13. Zakrzewska M., Wojcik I., Zakrzewski K., Polis L., Grajkowska W., Roszkowski M., Augelli B.J., Liberski P.P., and Rieske P. Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas. Cancer Genet Cytogenet 156 (2005) 179-182
14. Szybka M., Zawlik I., Kulczycka D., Golanska E., Jesien E., Kupnicka D., Stawski R., Piaskowski S., Bieniek E., Zakrzewska M., Kordek R., Liberski P.P., and Rieske P. Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53. Br J Cancer 98 (2008) 1431-1433
15. Birindelli S., Perrone F., Oggionni M., Lavarino C., Pasini B., Vergani B., Ranzani G.N., Pierotti M.A., and Pilotti S. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab Invest 81 (2001) 833-844
16. Warshawsky I., Shadrach B., Commane M., Prayson R.A.., Barnett G.H., Tubbs R.R., and Staugaitis S.M. Correlation of TP53 immunohistochemistry with TP53 mutations on gliomas [Abstract]. Mod Pathol 17 Suppl 1 (2004) 320A
17. Hirose T., Ishizawa K., Sugiyama K., Kageji T., Ueki K., and Kannuki S. Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types. Histopathology 52 (2008) 183-193